Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by DJDawgon Nov 27, 2023 11:24am
214 Views
Post# 35754435

RE:RE:RE:RE:RE:RE:RE:Exploring NMIBC Options in the face of BCG Shortages

RE:RE:RE:RE:RE:RE:RE:Exploring NMIBC Options in the face of BCG Shortages
Regrets on being late to the gem/doce discussion.

The protocol for the main study that I could find using gem/doce was
- 6 instillations, weekly for induction
- monthly up to 24 months

What is confusing about the main article is that it doesn't list anywhere (Eog, maybe you can see it) how many treatments the patients got so I'm going to have to assume that many/most got the monthly instills for up to 2 years.

I have such a hard time being impressed by something that maintains its CR rate by give the repeat treatment monthly and then quoting durable CR. It is just not as impressive as a treatment that has been given and then stopped with durable CR AFTER the last treatment. The nature of cancer is that it can often been smacked down but all it takes is one residual cancer cell to restart the entire process of growth and spread. So Ruvidar is still way impressive in terms of what it offers compared to monthly instills going on and on.
<< Previous
Bullboard Posts
Next >>